A five-judge bench of the Full Court of the Federal Court of Australia (Full Court) unanimously decided that Myriad Genetics Inc’s (Myriad) patent covering the isolated BRCA1 gene (Patent) is patentable subject matter in Australia. Link For an in-depth analysis of the ruling, take a look at some articles written by Mark Summerfield on Patentology:Link
Full Federal Court Confirms Patentability of Isolated Genes
supporting early entrepreneurship and innovation info@asiforum.net
Related Articles
-
Industry Mentoring in STEM
Fantastic new initiative from the Australian Academy of Technological Sciences and Engineering: Industry Mentoring in STEM (IMNIS). Why an...
-
Science Next Collaborative: a new approach to the commercial challenges of early career research
It cannot be disputed that Australian scientists are facing challenging times. Perhaps ‘challenging’ is an understatement. Australia is producing...
-
My experiences in the innovation sector; challenges, advantages
Reflections First, I’ll paint a little context about me. I work for ANDS , a Federally funded innovation project,...
-
Australian Innovation System Report 2015
The Australian Innovation System Report 2015, the sixth in the series, explores innovation through the lens of innovative entrepreneurship....
-
Boosting Australia’s Innovation Performance
Tony Peacock I was delighted to hear about the formation of ASIF, the Australian Science and Innovation Forum. As...
-
The Dynamics of Discovery…the start of the innovation process
From Archimedes to Edison, attempts to improve quality of life have dictated a need for advances in science and...
-
Is Commercialisation the Dark Side of research?
Star Wars fans – including me – celebrated Star Wars Day last week, on May the 4th… be with...
-
PRESS RELEASE: Missing opportunities in Australian Innovation
The Australian Council of Learned Academies (ACOLA) has reported that innovation in Australia is suffering from a lack of...
